Post

FDA clears Polymedco’s MI cardiac troponin test

Polymedco has received 510(k) clearance from the US Food and Drug Administration (FDA) for its rapid troponin assay as part …

Novocure’s TTFields device slows metastasis in NSCLC

Novocure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression …

Nexalin’s device improves symptoms of mild traumatic brain injury

Nexalin Technology has revealed positive data from a clinical trial that evaluated its neurostimulation device in veteran patients with combat-related …

Elekta and MSD team up for digital kidney cancer care

Elekta has announced a collaboration with Merck & Co (MSD) to enhance care for individuals with advanced renal cell carcinoma …

Medtronic swings FDA clearance for latest TAVR device

The US Food and Drug Administration (FDA) has granted approval to Medtronic the its Evolut FX+ transcatheter aortic valve replacement …